ArticleInternational journal of molecular medicine2019

EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR.

San-Hu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.